Mayo Clinic testing colon cancer breathalyzer in clinical trial: 4 insights
Rochester, Minn.-based Mayo Clinic is testing Owlstone Medical's ATLAS Headspace Sampler and Lonestar VOC Analyzer in a clinical trial evaluating bowel preparation, Business Weekly reports.
Here's what you should know:
1. In a pilot study, researchers collected volatile organic compound biomarkers from pre-procedural stool samples and analyzed them with the ATLAS Headspace Sampler and VOC Analyzer.
2. Researchers concluded the technology rapidly and effectively identifies patients inadequately prepped for colonoscopies with 100 percent sensitivity and specificity.
3. Gastroenterologists Liam Zakko, MD, and Kenneth Wang, MD, have launched a larger clinical trial of the technology. The physicians want to evaluate the technology as a pre-endoscopic test to ensure colonoscopies are only performed when patients are adequately prepped.
4. The gastroenterologists will present the trials results at Digestive Disease Week 2017 in Chicago, from May 6 to May 9.
More articles on gastroenterology:
Allergan collaborating with Novartis to treat non-alcoholic steatohepatitis: 4 notes
Allergan, Mauna Kea Technologies & more — 5 updates on GI companies
GI leader to know: Dr. Megan Adkins Adams of Michigan Medicine Gastroenterology Clinic
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- CDC chief fears deadly Candida auris could spread: 6 notes
- Survey says 33% of providers using telehealth services
- Payer group advocates for continuing cost sharing reductions — 4 key notes
- The Joint Commission Journal on Quality and Patient Safety adds associate editors
- Northwest Ohio Orthopedics & Sports Medicine opening surgery center: 4 key notes